10/09/21

Risk of Venous Thromboembolism Among Inflammatory Bowel Disease Patients Who Contract SARS-CoV-2

Nadim Mahmud, MD1,2; Alexandra Weiss, MD2; Chinmay Trivedi, MBBS1; Yu-Xiao Yang, MD1,3; James Lewis, MD2; Nabeel Khan, MD1,2Gastroenterology 2021 Jun 15;S0016-5085(21)03123-1. Introduction : Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic affecting over 166 million people…
10/09/21

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection

JR Allegretti, CR Kelly , A Grinspan, BH Mullish, J Hurtado, M Carrellas, J Marcus, JR Marchesi , JAK McDonald , Y Gerardin, M Silverstein, A Pechlivanis , GF Barker, JM Blanco, JL Alexander, KI Gallagher, W Pettee, E Phelps, …
10/09/21

Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease:long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource

Evangelos Stournaras, Wendi Qian , Apostolos Pappas, You Yi Hong, Rasha Shawky, UK IBD BioResource Investigators; Tim Raine, Miles Parkes.Gut 2021 Apr;70(4):677-686 Abstract Objective: Thiopurines are widely used as maintenance therapy in inflammatory bowel disease (IBD) but the evidence base…
10/09/21

Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease

Robert Battat, MD, Dana Lukin, MD, PhD, Ellen J Scherl, MD, Suresh Pola, MD, Anand Kumar, MD, Lauren Okada, Lei Yang, PhD, Anjali Jain, PhD, Corey A Siegel, MD, MSInflammatory Bowel Diseases, Volume 27, Issue 9, September 2021, Pages 1443–1451…
10/09/21

Comparison of short- and long-term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor therapy

Luc Manlay, Gilles Boschetti, Bruno Pereira, Bernard Flourié, Michel Dapoigny, Maud Reymond, Elisa Sollelis, Claire Gay, Mathilde Boube, Anthony Buisson, Stéphane NanceyAliment Pharmacol Ther 2021 Jun;53(12):1289-1299 Abstract BackgroundThe best option between vedolizumab and ustekinumab after anti-tumour necrosis factor (TNF) failure…
05/07/21

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme

Kevin L Winthrop, Edward V Loftus, Jr, Daniel C Baumgart, Walter Reinisch, Chudy I Nduaka, Nervin Lawendy, Gary Chan, Rajiv Mundayat, Gary S Friedman, Leonardo Salese ... Show more Journal of Crohn's and Colitis, Volume 15, Issue 6, June 2021,…
05/07/21

Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study

Iril Lovise Monstad, Inger Camilla Solberg, Milada Cvancarova, Oistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Eva Gunther, Bjørn Allan Moum, Njaal Stray, Morten Vatn ... Show more Journal of Crohn's and Colitis, Volume 15, Issue 6, June 2021, Pages 969–979, Abstract…
05/07/21

Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn’s Disease Regardless of Disease Location

Anthony Buisson, MD, PhD, Wing Yan Mak, MD, Michael J Andersen, Jr, BS, Donald Lei, MS, Joel Pekow, MD, Russell D Cohen, MD, Stacy A Kahn, MD, Bruno Pereira, PhD, David T Rubin, MD Inflammatory Bowel Diseases, Volume 27, Issue…
05/07/21

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

William J Sandborn, MD, Brian G Feagan, MD, Silvio Danese, MD, PhD, Christopher D O’Brien, MD, PhD, Elyssa Ott, MPH, Colleen Marano, PhD, Thomas Baker, MD, Yiying Zhou, PhD, Sheri Volger, MS, PhD, Ilia Tikhonov, MD, PhD ... Show more…
12/05/21

The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis

Rebecca K Grant, MSc, Gareth-Rhys Jones, PhD, Nikolas Plevris, MRCP, Ruairi W Lynch, PhD, Philip W Jenkinson, MRCS, Charlie W Lees, PhD, Thomas A Manship, MRCP, Fiona A M Jagger, William M Brindle, MRCP, Mrithula ShivakumarInflammatory Bowel Diseases, Volume 27,…
12/05/21

A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy

Nayantara Coelho-Prabhu, MD, David H Bruining, MD, William A Faubion, MD, Sunanda V Kane, MD, John B Kisiel, MD, Konstantinos A Papadakis, MD, Darrell S Pardi, MD, Laura E Raffals, MD, Kenneth W Schroeder, MD, William J Tremaine, MDInflammatory Bowel…
12/05/21

Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn’s Disease: A Multicentre Study

Mathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, Romain Altwegg, Cyrielle Gilletta, Pauline Veyrard, Guillaume Bouguen, Stephanie Viennot, Florian Poullenot, Jerome Filippi ... Show moreJournal of Crohn's and Colitis, Volume 15, Issue 2, February 2021, Pages 222–227, https://doi.org/10.1093/ecco-jcc/jjaa177 BackgroundThe approved maintenance regimens…